supp.fit

Iodine, Folic Acid and Iron: study protocols

6 study groups took Iodine together with Folic Acid and Iron. These are the doses the studies gave. They are not a recommendation.

Iodine: what the research found →

Dose per serving from research: Iodine

6 study groups in 4 studies say how much Iodine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mcg to 250 mcg, 100% of 6 study groups.

Daily doseStudy groups
100 mcg to 250 mcg
6

Dose per serving from research: Folic Acid

6 study groups in 4 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 67% of 6 study groups.

Daily doseStudy groups
250 mcg to 500 mcg
4
500 mcg to 1 mg
2

Dose per serving from research: Iron

6 study groups in 4 studies say how much Iron participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 67% of 6 study groups.

Daily doseStudy groups
10 mg to 25 mg
4
25 mg to 50 mg
2

Commonly used together

5 of 6 study groups took Iodine, Folic Acid and Iron with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin B12
3
Vitamin D
3
Zinc
3

6 study groups

Study
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
2021 · MMN group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi
250 mcg400 mcg20 mg—106
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
2021 · LNS group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi
250 mcg400 mcg20 mg—107
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
150 mcg400 mcg12 mg—870
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · control · Women planning pregnancy; generally healthy, recruited before conception
150 mcg400 mcg12 mg—859
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
220 mcg600 mcg27 mg165 days749
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
220 mcg600 mcg27 mg—176
Iodine, Folic Acid and Iron: study protocols | supp.fit